CA-HILLSTONE-NETWORKS
7.6.2022 08:02:11 CEST | Business Wire | Press release
Hillstone Networks , a leading provider of innovative and accessible cybersecurity solutions, today announced the global availability of their simplified portfolio that delivers on cyber resilience, securing critical assets against sophisticated, multifaceted cyberattacks and an expanding attack surface.
Today’s workforce and workloads require flexibility, quality of service, and above all, protection. Security solutions need to be equally flexible and deliver on enterprise-grade cyber resilience. The Hillstone Networks solutions have evolved from a network security platform, included in the Gartner Magic Quadrant for Enterprise Firewalls for 8 consecutive years, into a robust portfolio that delivers on cyber resilience, from edge to cloud, and everything in between, to over 23,000 customers worldwide.
At RSAC 2022, in San Francisco, Hillstone will showcase its broad range of solutions across these initiatives:
- SD-WAN : Hillstone Secure SD-WAN secures today’s borderless networks with granular visibility and enforcement into all interactions across all entry points into the network, with the ability to drill further into user, device, and access behavior.
- ZTNA : Hillstone ZTNA solution secures remote access for today’s work-from-anywhere deployments, or heavily regulated industries with sensitive data that need to secure their evolving edge perimeter. Fine-grained access controls allow for precise enforcement of privileges from wherever it’s needed.
- Microsegmentation : Hillstone CloudHive protects cloud-native and cloud-based apps, for dev/ops teams who rely on app portability and microservices, and cloud service providers where multi-tenancy can be risky without segmenting or isolating network access. Support for both VMware and OpenStack provide cross-platform portability across clouds.
- CWPP : Hillstone CloudArmour protects cloud applications running in public or multiple cloud environments, integrating into existing CI/CD and DevOps environments and processes with full application stack visibility. Protect bare metal hosts, virtual machines, containers, and serverless workloads.
- NDR : Hillstone sBDS delivers continuous network monitoring with an AI-driven network detection and response platform that collects and aggregates network traffic data, applying behavioral analysis and AI/ML, and delivering insights to security teams from a single view.
- XDR : Hillstone iSource rolls up all the key activities including threat detection, investigation, response, and real-time threat hunting into a single platform and get extensive visibility across all relevant threat data from device endpoints, applications, networks, and security devices, including 3rd party devices.
“Cyber-resiliency is the infrastructure’s ability to weather a storm of relentless attacks and bounce quickly back. Cyber-resilient infrastructure transforms traditional security, which is inflexible, static, and impractical, into a modernized and agile security plan that’s adaptive, dynamic, and realistic. This is the Hillstone vision and reflected in the solutions we deliver to the market,” states Tim Liu, CTO and co-founder, Hillstone Networks.
"Today's typical IT infrastructure environment is highly disaggregated in nature and presents complex challenges with respect to security. I believe Hillstone Networks delivers a suite of AI/ML enhanced cybersecurity solutions that are designed to provide visibility, ease of deployment, and simplify ongoing management through integration into existing SecOps frameworks," states Will Townsend, Vice President & Principal Analyst, Networking & Security Practices, Moor Insights & Strategy.
About Hillstone Networks
Hillstone Networks' innovative and accessible cybersecurity solutions reshape enterprise security, enabling cyber resilience while lowering TCO. By providing comprehensive visibility, superior intelligence, and rapid protection to see, understand, and act against multilayer, multistage cyberthreats, Hillstone is favorably rated by leading analysts and trusted by global companies. To learn more visit www.hillstonenet.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005278/en/
Link:
Social Media:
https://www.facebook.com/Hillstone-Networks-230976560386832/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom